Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal pethidine for postoperative pain in gynecologic oncology surgery
IRCT20240915063051N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of pethidine in postoperative pain (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Pain score, Received painkillers and 1 more. Started Apr 2023; status: completed.
02
Drugs
pethidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20240915063051N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240915063051N1.